πŸ‡ΊπŸ‡Έ FDA
Patent

US 8426379

POT1 alternative splicing variants

granted A61PA61P35/00

Quick answer

US patent 8426379 (POT1 alternative splicing variants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00